Pricing
Login
Home
Charts
Search
Watchlist
Products

Procter & Gamble Health Ltd

PGHL
₹5,589.50+0.96%20 Nov 2026
Reports
Pharma MNC Bulk Drugs

Procter & Gamble Health Ltd

PGHL
₹5,589.50
+0.96%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹9,278Cr
Close
Close Price
₹5,589.50
Industry
Industry
Pharma MNC Bulk Drugs
PE
Price To Earnings
24.43
PS
Price To Sales
6.22
Revenue
Revenue
₹1,491Cr
Rev Gr TTM
Revenue Growth TTM
16.05%
PAT Gr TTM
PAT Growth TTM
23.81%

Quarterly Results

Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
310252284313310311339325374370364382
Growth YoY
Revenue Growth YoY%
0.0-21.3-5.72.8-0.123.219.33.720.719.17.417.7
Expenses
ExpensesCr
208185236199186230248205263235264230
Operating Profit
Operating ProfitCr
10267481141238190120110136100152
OPM
OPM%
32.826.717.036.439.926.026.737.029.636.627.439.8
Other Income
Other IncomeCr
52-183434544364
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
777665566666
PBT
PBTCr
10063231111227989119109133129150
Tax
TaxCr
28166293117233031393339
PAT
PATCr
7247178291616689789596112
Growth YoY
PAT Growth YoY%
-6.2-21.3-43.725.626.131.4294.47.5-14.654.645.325.9
NPM
NPM%
23.318.45.926.329.319.719.527.320.825.526.429.1
EPS
EPS₹
43.428.09.549.654.836.939.953.346.757.057.967.2
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
310252284313310311339325374370364382
Growth YoY
Revenue Growth YoY%
0.0-21.3-5.72.8-0.123.219.33.720.719.17.417.7
Expenses
ExpensesCr
208185236199186230248205263235264230
Operating Profit
Operating ProfitCr
10267481141238190120110136100152
OPM
OPM%
32.826.717.036.439.926.026.737.029.636.627.439.8
Other Income
Other IncomeCr
52-183434544364
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
777665566666
PBT
PBTCr
10063231111227989119109133129150
Tax
TaxCr
28166293117233031393339
PAT
PATCr
7247178291616689789596112
Growth YoY
PAT Growth YoY%
-6.2-21.3-43.725.626.131.4294.47.5-14.654.645.325.9
NPM
NPM%
23.318.45.926.329.319.719.527.320.825.526.429.1
EPS
EPS₹
43.428.09.549.654.836.939.953.346.757.057.967.2

Profit & Loss

Standalone
Numbers
Percentage
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
9409936988491,3561,0091,1141,2301,1519341,4081,491
Growth
Revenue Growth%
8.35.7-29.721.6-25.610.510.3-6.450.716.1
Expenses
ExpensesCr
8568776217011,040763847905845616951992
Operating Profit
Operating ProfitCr
8311677148315246268325306318457498
OPM
OPM%
8.911.611.017.423.324.424.026.426.634.132.433.4
Other Income
Other IncomeCr
2324413169181318-51048
Interest Expense
Interest ExpenseCr
000001011011
Depreciation
DepreciationCr
232519212930272827172424
PBT
PBTCr
8311599158355233253314273312450521
Tax
TaxCr
303638561015661857277123141
PAT
PATCr
547961102254177193229201234327380
Growth
PAT Growth%
23.947.7-22.966.7-30.48.919.2-12.439.523.8
NPM
NPM%
5.78.08.712.018.717.517.318.717.525.123.225.5
EPS
EPS₹
32.347.756.6505.3153.1106.5116.0138.2121.1141.2196.9228.8
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
9409936988491,3561,0091,1141,2301,1519341,4081,491
Growth
Revenue Growth%
8.35.7-29.721.6-25.610.510.3-6.450.716.1
Expenses
ExpensesCr
8568776217011,040763847905845616951992
Operating Profit
Operating ProfitCr
8311677148315246268325306318457498
OPM
OPM%
8.911.611.017.423.324.424.026.426.634.132.433.4
Other Income
Other IncomeCr
2324413169181318-51048
Interest Expense
Interest ExpenseCr
000001011011
Depreciation
DepreciationCr
232519212930272827172424
PBT
PBTCr
8311599158355233253314273312450521
Tax
TaxCr
303638561015661857277123141
PAT
PATCr
547961102254177193229201234327380
Growth
PAT Growth%
23.947.7-22.966.7-30.48.919.2-12.439.523.8
NPM
NPM%
5.78.08.712.018.717.517.318.717.525.123.225.5
EPS
EPS₹
32.347.756.6505.3153.1106.5116.0138.2121.1141.2196.9228.8
Sales CAGR
1 Year51%
3 Years5%
5 Years7%
TTM16%
EBITDA CAGR
1 Year43%
3 Years12%
5 Years13%
TTM20%
PAT CAGR
1 Year39%
3 Years13%
5 Years13%
TTM24%
Avg. ROCE
1 Year86%
3 Years64%
5 Years55%
TTM79%
CFO / EBITDA
1 Year74%
3 Years68%
5 Years68%
TTM-

Balance Sheet

Standalone
Numbers
Percentage
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
171717171717171717171717
Reserves
ReservesCr
5756477171,524890687600734522520508641
Current Liabilities
Current LiabilitiesCr
165186225193227239232304219215255297
Non Current Liabilities
Non Current LiabilitiesCr
272933274243404637426260
Total Liabilities
Total LiabilitiesCr
7848799911,7591,1769868881,1017947948411,015
Current Assets
Current AssetsCr
5726367521,534954727608796524526556720
Non Current Assets
Non Current AssetsCr
212243239225222259280305270268285295
Total Assets
Total AssetsCr
7848799911,7591,1769868881,1017947948411,015
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
171717171717171717171717
Reserves
ReservesCr
5756477171,524890687600734522520508641
Current Liabilities
Current LiabilitiesCr
165186225193227239232304219215255297
Non Current Liabilities
Non Current LiabilitiesCr
272933274243404637426260
Total Liabilities
Total LiabilitiesCr
7848799911,7591,1769868881,1017947948411,015
Current Assets
Current AssetsCr
5726367521,534954727608796524526556720
Non Current Assets
Non Current AssetsCr
212243239225222259280305270268285295
Total Assets
Total AssetsCr
7848799911,7591,1769868881,1017947948411,015

Cash Flow

Standalone
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
8310754-130235247170236228169338
Investing Cash Flow
Investing Cash FlowCr
-68-75-481,270165-32-26-22-7101
Financing Cash Flow
Financing Cash FlowCr
-12-15-22-30-883-387-289-98-418-235-344
Net Cash Flow
Net Cash FlowCr
417-161,109-483-172-145116-197-56-5
Free Cash Flow
Free Cash FlowCr
387524-157212196132198207168323
CFO To PAT
CFO To PAT%
155.8135.387.9-128.292.6139.888.0102.8113.672.0103.3
CFO To EBITDA
CFO To EBITDA%
100.092.669.7-88.074.6100.563.372.774.653.074.0
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
8310754-130235247170236228169338
Investing Cash Flow
Investing Cash FlowCr
-68-75-481,270165-32-26-22-7101
Financing Cash Flow
Financing Cash FlowCr
-12-15-22-30-883-387-289-98-418-235-344
Net Cash Flow
Net Cash FlowCr
417-161,109-483-172-145116-197-56-5
Free Cash Flow
Free Cash FlowCr
387524-157212196132198207168323
CFO To PAT
CFO To PAT%
155.8135.387.9-128.292.6139.888.0102.8113.672.0103.3
CFO To EBITDA
CFO To EBITDA%
100.092.669.7-88.074.6100.563.372.774.653.074.0

Ratios

Standalone
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,2931,6562,1395,1206,7519,2866,9518,7138,3828,5367,9659,278
Price To Earnings
Price To Earnings
25.320.922.86.139.952.536.138.041.727.324.424.4
Price To Sales
Price To Sales
1.41.73.16.05.09.26.27.17.38.35.16.2
Price To Book
Price To Book
2.22.52.93.37.513.211.311.615.615.915.214.1
EV To EBITDA
EV To EBITDA
13.211.924.226.219.435.924.825.526.626.217.018.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
47.052.656.756.356.758.860.062.864.166.2
OPM
OPM%
8.911.611.017.423.324.424.026.426.634.132.433.4
NPM
NPM%
5.78.08.712.018.717.517.318.717.525.123.225.5
ROCE
ROCE%
14.117.413.510.339.132.941.041.350.057.385.979.3
ROE
ROE%
9.111.98.36.628.025.131.230.637.343.762.357.7
ROA
ROA%
6.89.06.25.821.617.921.720.825.329.538.937.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,2931,6562,1395,1206,7519,2866,9518,7138,3828,5367,9659,278
Price To Earnings
Price To Earnings
25.320.922.86.139.952.536.138.041.727.324.424.4
Price To Sales
Price To Sales
1.41.73.16.05.09.26.27.17.38.35.16.2
Price To Book
Price To Book
2.22.52.93.37.513.211.311.615.615.915.214.1
EV To EBITDA
EV To EBITDA
13.211.924.226.219.435.924.825.526.626.217.018.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
47.052.656.756.356.758.860.062.864.166.2
OPM
OPM%
8.911.611.017.423.324.424.026.426.634.132.433.4
NPM
NPM%
5.78.08.712.018.717.517.318.717.525.123.225.5
ROCE
ROCE%
14.117.413.510.339.132.941.041.350.057.385.979.3
ROE
ROE%
9.111.98.36.628.025.131.230.637.343.762.357.7
ROA
ROA%
6.89.06.25.821.617.921.720.825.329.538.937.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr46,20717,64015,4199,2787,9287,3844,784
Close PriceClose₹2,727.603,856.006,167.505,589.503,442.403,206.101,367.60
IndustryIndustryPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk Drugs
Price To EarningsPE40.8520.5386.7624.4328.3520.26
Price To SalesPS11.116.655.936.228.104.0514.22
RevenueRevenueCr4,1592,6542,6021,4919791,822336
Revenue Growth TTMRev Gr TTM%12.1%11.8%29.7%16.1%22.7%-5.7%-5.2%
PAT Growth TTMPAT Gr TTM%20.0%2.4%-10.8%23.8%28.4%2.3%-103.7%
Market CapitalizationMkt CapCr46,20717,64015,4199,2787,9287,3844,784
Close PriceClose₹2,727.603,856.006,167.505,589.503,442.403,206.101,367.60
IndustryIndustryPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk Drugs
Price To EarningsPE40.8520.5386.7624.4328.3520.26
Price To SalesPS11.116.655.936.228.104.0514.22
RevenueRevenueCr4,1592,6542,6021,4919791,822336
Revenue Growth TTMRev Gr TTM%12.1%11.8%29.7%16.1%22.7%-5.7%-5.2%
PAT Growth TTMPAT Gr TTM%20.0%2.4%-10.8%23.8%28.4%2.3%-103.7%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
ResultPPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
ResultPPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews